Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Non-cash Items: 2024-2025

Historic Non-cash Items for Harmony Biosciences Holdings (HRMY) over the last 2 years, with Sep 2025 value amounting to $5.5 million.

  • Harmony Biosciences Holdings' Non-cash Items rose 27.93% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 27.93%. This contributed to the annual value of $4.4 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Non-cash Items stood at $5.5 million, which was up 11.94% from $4.9 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Non-cash Items' 5-year high stood at $36.9 million during Q1 2025, with a 5-year trough of $4.3 million in Q3 2024.
  • In the last 2 years, Harmony Biosciences Holdings' Non-cash Items had a median value of $5.2 million in 2025 and averaged $14.0 million.
  • Over the last 5 years, Harmony Biosciences Holdings' Non-cash Items had its largest YoY gain of 27.93% in 2025, and its largest YoY loss of 82.28% in 2025.
  • Harmony Biosciences Holdings' Non-cash Items (Quarterly) stood at $4.4 million in 2024, then grew by 27.93% to $5.5 million in 2025.
  • Its last three reported values are $5.5 million in Q3 2025, $4.9 million for Q2 2025, and $36.9 million during Q1 2025.